$PFHO
PACIFIC HEALTH CARE ORGANIZATION INC

2023 Q3 Form 10-Q Financial Statement

#000118518523000869 Filed on August 18, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $1.376M $1.299M
YoY Change -5.36% -7.25%
Cost Of Revenue $270.0K $267.4K
YoY Change 12.71% 5.13%
Gross Profit $1.110M $1.032M
YoY Change -8.6% -10.0%
Gross Profit Margin 80.67% 79.41%
Selling, General & Admin $950.0K $877.1K
YoY Change 1.3% -8.99%
% of Gross Profit 85.59% 85.03%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.936K $9.337K
YoY Change -7.5% 0.43%
% of Gross Profit 0.81% 0.91%
Operating Expenses $1.229M $1.154M
YoY Change 3.54% -5.99%
Operating Profit $147.0K $145.1K
YoY Change -44.93% -16.17%
Interest Expense $100.0K $100.2K
YoY Change
% of Operating Profit 68.02% 69.02%
Other Income/Expense, Net $4.524K $30.75K
YoY Change 56.11% -33.6%
Pretax Income $249.0K $245.3K
YoY Change -6.71% 41.68%
Income Tax $69.90K $68.85K
% Of Pretax Income 28.07% 28.07%
Net Earnings $179.1K $176.4K
YoY Change -6.71% 41.68%
Net Earnings / Revenue 13.02% 13.58%
Basic Earnings Per Share $0.01 $0.01
Diluted Earnings Per Share $0.01 $0.01
COMMON SHARES
Basic Shares Outstanding 12.80M shares 12.80M shares
Diluted Shares Outstanding 12.82M shares 12.82M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.13M $9.964M
YoY Change -4.79% -4.28%
Cash & Equivalents $2.360M $2.296M
Short-Term Investments $7.770M $7.667M
Other Short-Term Assets $270.0K $240.8K
YoY Change 71.6% 38.14%
Inventory
Prepaid Expenses $189.4K $158.8K
Receivables $832.8K $863.4K
Other Receivables $0.00 $3.000K
Total Short-Term Assets $11.23M $11.07M
YoY Change -3.69% -3.92%
LONG-TERM ASSETS
Property, Plant & Equipment $73.88K $80.16K
YoY Change -15.08% -16.68%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.110K $7.110K
YoY Change 7.69% -78.71%
Total Long-Term Assets $80.99K $87.27K
YoY Change -13.48% -32.66%
TOTAL ASSETS
Total Short-Term Assets $11.23M $11.07M
Total Long-Term Assets $80.99K $87.27K
Total Assets $11.31M $11.16M
YoY Change -3.77% -4.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $121.9K $80.27K
YoY Change 36.48% -24.67%
Accrued Expenses $314.7K $344.3K
YoY Change 27.26% 12.51%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $776.5K $799.2K
YoY Change 84.25% 57.54%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $776.5K $799.2K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $792.2K $814.9K
YoY Change 84.83% 58.39%
SHAREHOLDERS EQUITY
Retained Earnings $10.09M $9.914M
YoY Change -7.4% -7.42%
Common Stock $12.80K $12.80K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.52M $10.34M
YoY Change
Total Liabilities & Shareholders Equity $11.31M $11.16M
YoY Change -3.77% -4.24%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $179.1K $176.4K
YoY Change -6.71% 41.68%
Depreciation, Depletion And Amortization $8.936K $9.337K
YoY Change -7.5% 0.43%
Cash From Operating Activities $160.0K $308.2K
YoY Change -30.99% -359.13%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $1.260K
YoY Change -100.0% -111.41%
Acquisitions
YoY Change
Other Investing Activities $0.00 $1.105M
YoY Change
Cash From Investing Activities $0.00 $1.104M
YoY Change -100.0% -10101.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -100.0K -1.111M
YoY Change
NET CHANGE
Cash From Operating Activities 160.0K 308.2K
Cash From Investing Activities 0.000 1.104M
Cash From Financing Activities -100.0K -1.111M
Net Change In Cash 60.00K 301.4K
YoY Change -74.07% -331.89%
FREE CASH FLOW
Cash From Operating Activities $160.0K $308.2K
Capital Expenditures $0.00 $1.260K
Free Cash Flow $160.0K $306.9K
YoY Change -31.13% -384.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-50009
dei Entity Registrant Name
EntityRegistrantName
PACIFIC HEALTH CARE ORGANIZATION, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0285238
dei Entity Address Address Line1
EntityAddressAddressLine1
19800 MacArthur Boulevard, Suites 306 & 307
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92612
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
721-8272
dei Security12b Title
Security12bTitle
None
dei Trading Symbol
TradingSymbol
N/A
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12800000 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2296207 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2036432 usd
CY2023Q2 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
7667386 usd
CY2022Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
8748435 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8971 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7807 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
863420 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
934990 usd
CY2023Q2 us-gaap Other Receivables
OtherReceivables
3000 usd
CY2022Q4 us-gaap Other Receivables
OtherReceivables
3000 usd
CY2023Q2 us-gaap Prepaid Taxes
PrepaidTaxes
82000 usd
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
0 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
158832 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
175355 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
11070845 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
11898212 usd
CY2023Q2 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
256681 usd
CY2022Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
256500 usd
CY2023Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
21620 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
20328 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
278301 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
276828 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
198139 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
179423 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
80162 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
97405 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
50137 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7110 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6602 usd
CY2023Q2 us-gaap Assets
Assets
11158117 usd
CY2022Q4 us-gaap Assets
Assets
12052356 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
80268 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
263022 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
344259 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
332551 usd
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
123357 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3132 usd
CY2023Q2 us-gaap Loans Payable
LoansPayable
207616 usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
37000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
39620 usd
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
43711 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
33544 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
799211 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
708869 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10517 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15679 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15679 usd
CY2023Q2 us-gaap Liabilities
Liabilities
814890 usd
CY2022Q4 us-gaap Liabilities
Liabilities
735065 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
16 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
16 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
12800 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
12800 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
416057 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
416057 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
9914354 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10888418 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
10343227 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11317291 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11158117 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12052356 usd
CY2023Q2 us-gaap Revenues
Revenues
1298894 usd
CY2022Q2 us-gaap Revenues
Revenues
1400451 usd
us-gaap Revenues
Revenues
2611537 usd
us-gaap Revenues
Revenues
2827834 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9337 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9297 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18716 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13492 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
934 usd
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1164 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4783 usd
CY2023Q2 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
60563 usd
CY2022Q2 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
56206 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
116817 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
110161 usd
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
626532 usd
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
686240 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1288756 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1319612 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
101101 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
79774 usd
us-gaap Professional Fees
ProfessionalFees
174203 usd
us-gaap Professional Fees
ProfessionalFees
146638 usd
CY2023Q2 us-gaap General Insurance Expense
GeneralInsuranceExpense
65115 usd
CY2022Q2 us-gaap General Insurance Expense
GeneralInsuranceExpense
75211 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
148596 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
158877 usd
CY2023Q2 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
171523 usd
CY2022Q2 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
132820 usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
349282 usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
276598 usd
CY2023Q2 us-gaap Other Expenses
OtherExpenses
30752 usd
CY2022Q2 us-gaap Other Expenses
OtherExpenses
46313 usd
us-gaap Other Expenses
OtherExpenses
64754 usd
us-gaap Other Expenses
OtherExpenses
56502 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
87919 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
141472 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
221675 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
305944 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1153776 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1227333 usd
us-gaap Operating Expenses
OperatingExpenses
2383963 usd
us-gaap Operating Expenses
OperatingExpenses
2392607 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
145118 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
173118 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
227574 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
435227 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
100158 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
199974 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
0 usd
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
100158 usd
CY2022Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
199974 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
245276 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
173118 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
427548 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
435227 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
68849 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48594 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
120012 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
122168 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
176427 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
124524 usd
us-gaap Net Income Loss
NetIncomeLoss
307536 usd
us-gaap Net Income Loss
NetIncomeLoss
313059 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10824405 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
188535 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
11012940 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
124524 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
11137464 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11317291 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
131109 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
11448400 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
176427 usd
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1280000 usd
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1600 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
10343227 usd
us-gaap Net Income Loss
NetIncomeLoss
307536 usd
us-gaap Net Income Loss
NetIncomeLoss
313059 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18716 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13492 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1164 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4783 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
24405 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-70406 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13140 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-10055 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
16523 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-77358 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
0 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-19779 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
82000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
508 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6602 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-182754 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
61651 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
11708 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-9502 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
10167 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
9847 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
120225 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
14388 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
266778 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
340452 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-8748435 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
0 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
7642981 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1473 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17166 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1103981 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17166 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
1110984 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1110984 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
259775 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
323286 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2036432 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10085372 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2296207 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10408658 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
82000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
88000 usd
us-gaap Dividends
Dividends
170616 usd
us-gaap Dividends
Dividends
0 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
8971 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7807 usd
CY2022Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
10730 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
11372 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
20693 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
86956 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1
CY2023Q2 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2023-06-05
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
us-gaap Dividends Cash
DividendsCash
1281600 usd
CY2023Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
170616 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Entity Central Index Key
EntityCentralIndexKey
0001138476

Files In Submission

Name View Source Status
0001185185-23-000869-index-headers.html Edgar Link pending
0001185185-23-000869-index.html Edgar Link pending
0001185185-23-000869.txt Edgar Link pending
0001185185-23-000869-xbrl.zip Edgar Link pending
ex_561380.htm Edgar Link pending
ex_561381.htm Edgar Link pending
ex_561382.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pacifichco20230630_10q.htm Edgar Link pending
pfho-20230630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pfho-20230630_def.xml Edgar Link unprocessable
pfho-20230630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pfho-20230630_lab.xml Edgar Link unprocessable
pfho-20230630_pre.xml Edgar Link unprocessable
pacifichco20230630_10q_htm.xml Edgar Link completed